Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee-Shing Chang

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of General Internal Medicine|August 4, 2017
Checkpoint Inhibitor-Associated HypophysitisLee-Shing Chang, Maria A Yialamas
Journal of the American College of Cardiology|March 14, 2020
Training the Next Generation of Cardiometabolic SpecialistsCian P McCarthy, Lee-Shing Chang, Muthiah Vaduganathan
Current Diabetes Reports|December 6, 2019
Bridging the Gap for Patients with Diabetes and Cardiovascular Disease Through Cardiometabolic CollaborationLee-Shing Chang, Muthiah Vaduganathan, Jorge Plutzky, et al.
Frontiers in Endocrinology|April 30, 2021
Coexistence of Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes and PancreatitisAmy L Zhang, Fang Wang, Lee-Shing Chang, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 2, 2018
Extracting Healthcare Quality Information from Unstructured DataShervin Malmasi, Naoshi Hosomura, Lee-Shing Chang, et al.
Current Diabetes Reports|September 28, 2021
Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 DiabetesAna Maria Stanton, Muthiah Vaduganathan, Lee-Shing Chang, et al.
JAMA Cardiology|June 26, 2020
Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A ReviewMichael C Honigberg, Lee-Shing Chang, Darren K McGuire, et al.
Endocrine Reviews|September 6, 2018
Endocrine Toxicity of Cancer Immunotherapy Targeting Immune CheckpointsLee-Shing Chang, Romualdo Barroso-Sousa, Sara M Tolaney, et al.
JAMA Network Open|February 28, 2023
Assessment of Sex Disparities in Nonacceptance of Statin Therapy and Low-Density Lipoprotein Cholesterol Levels Among Patients at High Cardiovascular RiskC Justin Brown, Lee-Shing Chang, Naoshi Hosomura, et al.
Obesity (Silver Spring, Md.)|June 10, 2021
Patient-provider discussions of bariatric surgery and subsequent weight changes and receipt of bariatric surgeryLee-Shing Chang, Shervin Malmasi, Naoshi Hosomura, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of General Internal Medicine|August 4, 2017
Checkpoint Inhibitor-Associated HypophysitisLee-Shing Chang, Maria A Yialamas
Journal of the American College of Cardiology|March 14, 2020
Training the Next Generation of Cardiometabolic SpecialistsCian P McCarthy, Lee-Shing Chang, Muthiah Vaduganathan
Current Diabetes Reports|December 6, 2019
Bridging the Gap for Patients with Diabetes and Cardiovascular Disease Through Cardiometabolic CollaborationLee-Shing Chang, Muthiah Vaduganathan, Jorge Plutzky, et al.
Frontiers in Endocrinology|April 30, 2021
Coexistence of Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes and PancreatitisAmy L Zhang, Fang Wang, Lee-Shing Chang, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 2, 2018
Extracting Healthcare Quality Information from Unstructured DataShervin Malmasi, Naoshi Hosomura, Lee-Shing Chang, et al.
Current Diabetes Reports|September 28, 2021
Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 DiabetesAna Maria Stanton, Muthiah Vaduganathan, Lee-Shing Chang, et al.
JAMA Cardiology|June 26, 2020
Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A ReviewMichael C Honigberg, Lee-Shing Chang, Darren K McGuire, et al.
Endocrine Reviews|September 6, 2018
Endocrine Toxicity of Cancer Immunotherapy Targeting Immune CheckpointsLee-Shing Chang, Romualdo Barroso-Sousa, Sara M Tolaney, et al.
JAMA Network Open|February 28, 2023
Assessment of Sex Disparities in Nonacceptance of Statin Therapy and Low-Density Lipoprotein Cholesterol Levels Among Patients at High Cardiovascular RiskC Justin Brown, Lee-Shing Chang, Naoshi Hosomura, et al.
Obesity (Silver Spring, Md.)|June 10, 2021
Patient-provider discussions of bariatric surgery and subsequent weight changes and receipt of bariatric surgeryLee-Shing Chang, Shervin Malmasi, Naoshi Hosomura, et al.
Pageof 2